Fortress Biotech (NASDAQ: FBIO) is engaged in the acquisition, development and commercialization of high-potential marketed and development-stage drugs and drug candidates in six large-market areas, including oncology, rare diseases and gene therapy. The innovative biopharmaceutical company currently has nine marketed prescription pharmaceutical products and more than thirty programs in development at Fortress, at its majority-owned and majority-controlled partners and at partners it founded and in which it holds significant minority ownership positions.
The company has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca plc, City of Hope, Fred Hutchinson Cancer Research Center, St. Jude Children’s Research Hospital, Nationwide Children’s Hospital and Sentynl Therapeutics, Inc. Driven by a world-class business development team that is focused on further expanding the company’s portfolio of product opportunities, Fortress is advancing its diversified pipeline through a streamlined operating structure that fosters efficient drug development.
To schedule a one-on-one meeting, please contact your Roth representative.
To view IBN’s virtual coverage of Roth’s 34th Annual Conference, visit https://ibn.fm/Roth2022
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at Roth’s 34th Annual Conference. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Los Angeles, California